We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$859M
AUM Growth
-$429M
(-33%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-51.43%
Top 10 Holdings %
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gossamer Bio
GOSS
|
+$5.95M |
| 2 |
Marvell Technology
MRVL
|
+$4M |
| 3 |
Apple
AAPL
|
+$3.97M |
| 4 |
Walt Disney
DIS
|
+$3.95M |
| 5 |
Rollins
ROL
|
+$3.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$7.11M |
| 2 |
Intercontinental Exchange
ICE
|
+$6.91M |
| 3 |
Dentsply Sirona
XRAY
|
+$6.81M |
| 4 |
Cisco
CSCO
|
+$6.77M |
| 5 |
Qorvo
QRVO
|
+$6.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.95% |
| 2 | Consumer Discretionary | 16.59% |
| 3 | Industrials | 13.62% |
| 4 | Financials | 13.07% |
| 5 | Healthcare | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Tandem Diabetes Care
TNDM
$1.38B
| $461K | 0.05% |
+10,265
| New | +$465K |
|
527
Olin
OLN
$2.17B
| $461K | 0.05% |
+8,701
| New | +$462K |
|
528
Opko Health
OPK
$978M
| $457K | 0.05% |
365,283
+15,720
| +4% | +$24.8K |
|
|
P
529
Everpure Inc
P
$27.9B
| $456K | 0.05% |
17,051
-99,076
| -85% | -$2.88M |
|
530
Relmada Therapeutics
RLMD
$574M
| $456K | 0.05% |
+130,711
| New | +$1.15M |
|
|
HTLF
531
DELISTED
Heartland Financial USA, Inc.
HTLF
| $456K | 0.05% |
+9,775
| New | +$462K |
|
532
Enviri
NVRI
$671M
| $455K | 0.05% |
72,383
-69,797
| -49% | -$416K |
|
533
Allegiant Air
ALGT
$2.82B
| $455K | 0.05% |
6,690
-2,245
| -25% | -$164K |
|
534
Pulmonx
LUNG
$87M
| $454K | 0.05% |
+53,851
| New | +$512K |
|
535
Federal Signal
FSS
$8.09B
| $452K | 0.05% |
+9,737
| New | +$447K |
|
536
SM Energy
SM
$7.44B
| $452K | 0.05% |
+12,974
| New | +$539K |
|
|
RXDX
537
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $451K | 0.05% |
4,102
-22,533
| -85% | -$1.46M |
|
538
C3.ai
AI
$1.56B
| $449K | 0.05% |
40,148
+29,791
| +288% | +$373K |
|
539
Castle Biosciences
CSTL
$953M
| $449K | 0.05% |
19,056
-3,330
| -15% | -$77.2K |
|
|
TSP
540
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $448K | 0.05% |
+273,203
| New | +$973K |
|
541
Chefs' Warehouse
CHEF
$4.49B
| $447K | 0.05% |
+13,425
| New | +$468K |
|
542
Harmonic Inc
HLIT
$1.34B
| $443K | 0.05% |
33,828
-69,174
| -67% | -$965K |
|
543
International Money Express
IMXI
$370M
| $442K | 0.05% |
18,122
-20,977
| -54% | -$482K |
|
|
MRC
544
DELISTED
MRC Global
MRC
| $440K | 0.05% |
38,020
-20,678
| -35% | -$218K |
|
545
Cardlytics
CDLX
$23.3M
| $440K | 0.05% |
7,614
-524
| -6% | -$32.4K |
|
546
Teekay Tankers
TNK
$2.66B
| $439K | 0.05% |
14,256
-46,577
| -77% | -$1.48M |
|
|
DO
547
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $439K | 0.05% |
+42,227
| New | +$386K |
|
548
Usana Health Sciences
USNA
$421M
| $437K | 0.05% |
8,206
-1,104
| -12% | -$59.8K |
|
|
JAMF
549
DELISTED
Jamf
JAMF
| $435K | 0.05% |
20,445
-15,194
| -43% | -$334K |
|
550
Antero Midstream
AM
$10.4B
| $434K | 0.05% |
40,224
-158,887
| -80% | -$1.69M |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
OFS
LOAME
DP
Occudo Quantitative Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.
- Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
- Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
- Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
- Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
- Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
- Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
- Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.
Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.